Thor Medical ASA (LTS:0R6Y) Interest Expense : kr0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Thor Medical ASA Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Thor Medical ASA's interest expense for the three months ended in Dec. 2023 was kr 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was kr0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Thor Medical ASA's Operating Income for the three months ended in Dec. 2023 was kr 0.00 Mil. Thor Medical ASA's Interest Expense for the three months ended in Dec. 2023 was kr 0.00 Mil. Thor Medical ASA has no long-term debt ⁽¹⁾. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Thor Medical ASA Interest Expense Historical Data

The historical data trend for Thor Medical ASA's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thor Medical ASA Interest Expense Chart

Thor Medical ASA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-0.77

-0.47

-0.41

-0.17

Thor Medical ASA Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Dec22	Jun23	Dec23
Interest Expense	Get a 7-Day Free Trial															-0.12	-0.13	-	-	-

Thor Medical ASA Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

Thor Medical ASA (LTS:0R6Y) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Thor Medical ASA's Interest Expense for the three months ended in Dec. 2023 was kr0.00 Mil. Its Operating Income for the three months ended in Dec. 2023 was kr0.00 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was kr0.00 Mil.

Thor Medical ASA's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Thor Medical ASA had no long-term debt ⁽¹⁾.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Thor Medical ASA has no debt.

Thor Medical ASA (LTS:0R6Y) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Thor Medical ASA (LTS:0R6Y) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

TRMED:Norway 8NN:Germany

Address

Kjelsasveien 168 B, Oslo, NOR, 0884

Website

https://www.nordicnanovector.com

Nordic Nanovector ASA is a biopharmaceutical company. It is engaged in the development and commercialization of targeted therapeutics to improve the lives of patients with haematological cancers, such as non-Hodgkin lymphoma and leukaemia. The company's main clinical stage product is Betalutin.

Thor Medical ASA (LTS:0R6Y) Headlines

No Headlines